openPR Logo
Press release

Molecular Diagnostics Market focuses On Top Companies, Research Methodology, Drivers and Opportunities

07-21-2017 03:12 PM CET | Health & Medicine

Press release from: TMR Research

Molecular Diagnostics Market focuses On Top Companies,

Global Molecular Diagnostics Market: Overview

Molecular diagnostics refers to a collection of techniques used to analyze biological markers in the individual’s genetic code. The technique is used in diagnosing and monitoring diseases, detecting risks, and deciding suitable therapies for individual patients. It finds applications in blood screening, oncology, microbiology, and genetic tests. The technologies commonly employed in this technique are polymerase chain reaction (PCR), hybridization, isothermal nucleic acid amplification technology (INAAT), and DNA sequencing and next-generation sequencing. Some of the products and services used in the technique are instruments, reagents and kits, and software and services.

Global Molecular Diagnostics Market: Key Trends

The transformative and dynamic nature of molecular diagnostics has facilitated it in evolving as an attractive segment in the global in vitro diagnostics (IVD) industry. It has paved way for advancements in medical research and treatment of numerous diseases. The global demand for molecular diagnostics methodologies is largely supplemented by high sensitivity, accuracy, easy workflow, cost-effective testing, and fast turnaround time offered by these testing modalities.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1886

In addition, these merits have created a gateway for personalized medicines, thus providing momentum to the global market. Moreover, the increasing prevalence of various types of cancer and infectious diseases is augmenting the market. Furthermore, reforms in the U.S. reimbursement scenario are working in favor of the overall market. However, delays in approvals of new molecular diagnostic tests due to the complex regulatory framework are limiting the market from realizing its full potential.

Global Molecular Diagnostics Market: Market Potential

Acquisitions and partnerships have emerged as a common trend in the global molecular diagnostics market over the past few years and are anticipated to continue in the coming years as well. For instance, in September 2016, Danaher acquired molecular diagnostics firm Cepheid for approximately US$4 bn. Another case in point is Qiagen N.V., which in July 2015 collaborated with multiplex clinical molecular diagnostics and multiplex molecular technologies developer Seegene Inc. Such deals are likely to make way for the development of novel diagnostics, which will not only help players in broadening their product offerings but also in making the future of the overall market bright.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1886

Global Molecular Diagnostics Market: Geographical Segmentation

In terms of geography, the report presents an analysis of the market in North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. North America will represent a large share in the market throughout the forecast period. The growth of the region can be attributed to the presence of well-established and advanced laboratory accreditation infrastructure, government initiatives promoting PoC facilities and awareness regarding the benefits of early diagnosis, and the increasing expenditure on healthcare.

Asia Pacific is expected to register a significant CAGR during the same period, with emerging countries such as India and China being the sights of high growth. The improving healthcare infrastructure, high unmet needs, and growing geriatric populations are attracting global players to invest in the region. The increasing external funding for clinical studies is likely to drive the growth of the region.

Get Discount @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=1886

Global Molecular Diagnostics Market: Competitive Landscape

A raft of players in the global molecular diagnostics market is entering into strategic partnerships with biotech firms to provide novel diagnostics solutions in order to enhance their visibility. Companies are investing hefty funds in research and development activities to introduce cost-effective and innovative products that will help them in expanding their product portfolio. Several participants are focusing towards business expansion through mergers and acquisitions, which is likely to intensify the competition in the market in the near future.

Some of the prominent companies operating in the market are Abbott Molecular, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services Inc., Bio-Rad Laboratories, Inc., Alere Inc., Dako, Siemens Healthcare, Novartis AG, Becton, Dickinson and Company, Bayer AG, Danaher Corporation, Hologic, Inc. (Gen Probe), and Qiagen.

About TMR Research :

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Molecular Diagnostics Market focuses On Top Companies, Research Methodology, Drivers and Opportunities here

News-ID: 635676 • Views: 217

More Releases from TMR Research

Scleroderma Therapeutics Market Set to Surge Significantly During 2028 | Corbus …
Global Scleroderma Therapeutics Market: Overview Global scleroderma therapeutics market is experiencing a major growth in coming years. The growth of the market is majorly driven by rising off-label use of drugs approved for symptomatic indications, for instance rheumatoid arthritis. Moreover, lack of therapies and rising prevalence of off-label drugs are some of the key factors that are promoting the growth of global scleroderma therapeutics market. Moreover, growing developments in the field
Narcolepsy Drugs Market Trends and Dynamic 2028
Global Narcolepsy Drugs Market: Overview The narcolepsy drug pipeline has been dotted with medications that can target several symptoms of neurological sleep disorder. These symptoms are characterized notably under narcolepsy type 1 and narcolepsy type 2. An array of psychostimulants have gained favor among clinicians as third-line therapy. The global narcolepsy market has made strides driven by advances adjunctive behavioral techniques. To know Untapped Opportunities in the Market https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6068 Moreover, constant development of
Scleroderma Therapeutics Market Scope, Segmentation, Development and Opportuniti …
Global Scleroderma Therapeutics Market: Overview Global scleroderma therapeutics market is experiencing a major growth in coming years. The growth of the market is majorly driven by rising off-label use of drugs approved for symptomatic indications, for instance rheumatoid arthritis. Moreover, lack of therapies and rising prevalence of off-label drugs are some of the key factors that are promoting the growth of global scleroderma therapeutics market. Moreover, growing developments in the field
Anti-Acne Cosmetics Market Projected to Witness a Double-Digit CAGR During 2028 …
Anti-Acne Cosmetics Market: Introduction Now-a-days, cosmetic companies are coming up with advanced beauty products that claim to reduce the acne, along with better complexion care. These companies test and come up with advanced version of their existing products, along with several new products to meet the customers’ demand. Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=5853 Among several cosmetic products available in the market, creams and lotions are used at a large scale.

All 5 Releases


More Releases for Molecular

New Study On Molecular Pump Market 2018 Global Analysis By Key Players – Turbo …
Molecular Pump Industry research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. Get Exclusive FREE PDF Sample Copy of This Report @ https://www.upmarketresearch.com/home/requested_sample/7319 UpMarketResearch offers a latest published report on “Global Molecular Pump Market Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to
Molecular Diagnostics Market - Global Industry Insights
Molecular diagnostics tests are used for detecting disturbance between specific sequences in DNA or RNA, which may be associated with disease. The disturbance between a single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and others factors lead to various diseases. Disease that are diagnosed by using molecular diagnostic test includes infectious diseases, oncology, virology, and STDs. Increasing incidence and prevalence of infectious disease and cancer is expected to be a major factor
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Zeolite Molecular Sieves Market
Reports And Markets Publish a New Market Research Report On –"Zeolite Molecular Sieves Market - Segmented by Raw Material, End-user Industry, and Geography - Trends and Forecasts (2017 - 2022)" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/1086383-global-zeolite-molecular-sieves-market-segmented-forecasts-2017-2022 The Global Zeolite Molecular Sieve Market has been estimated at USD XX billion in 2015 and is projected to reach USD XX billion by 2020, at a CAGR of XX% during
Automated Molecular Diagnostics Testing System Market
The technological developments in genetic engineering has created many new aspects in diagnostic sciences. The molecular diagnostic techniques are used for understanding the biological samples and their genetic code and figure out the irregularities caused in an individual’s DNA. The molecular diagnostic involves various techniques which are time consuming, costly and require expertise to perform. These techniques are also subjected to errors which may lead to wrong interpretation of data
Global Molecular Biomarkers Sales Market Report 2017
This report studies sales (consumption) of Molecular Biomarkers in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Alere Atossa Genetics Biophysical Abbott BioCept BioTheranostics DiagnoCure GenomeDx Genomic Health Gen-Probe Life Technologies 20/20 GeneSystems Cynvenio Dako (Agilent) Epic Sciences Foundation Medicine Genomic Health Molecular Response Nodality PGD To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=984410&type=E Market Segment by Regions, this report splits Global into several key Regions, with sales